TECH vs ZBH · P/E 65, rev $1.22B vs P/E 23, rev $7.68B
Bio-Techne Corp (TECH) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported ZBH revenue for 2024-12-31 was $7.68B. Net income was $905.3M. Revenue was up 3.8% from 2023-12-31 to 2024-12-31. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the TECH and ZBH stock pages for the full models.
Not investment advice.